SMA hosted a speaker session, presented by Dr. Nicholas Wright (Georgetown University, University College London, and New America), Dr. James Giordano (Georgetown University and US Naval War College), and Dr. Diane DiEuliis (National Defense University), as a part of its SMA NDU Innovation Speaker Series.
Dr. Wright began the group’s presentation by stating that commercial and government spending on research and development (R&D) related to human biology has increased. He explained that biotech, or technology that incorporates biological materials, has become a focus of many countries across the globe. This new focus on biotech is partially due to the decreasing cost and increasing ease of creation of products, such as vaccines, and partially as a result of new global events—most notably, the spread of the COVID-19 pandemic. In response to the pandemic, China and Russia have developed their own COVID-19 vaccines and have provided them to other countries as geopolitical tools. Dr. Wright argued that the US and its allies should work together to provide their own humanitarian assistance and vaccines to developing countries and, as a byproduct, increase their own global influence. He then used the AstraZeneca vaccine, which was created in the UK, as a case study for why cooperation among democratic allies is crucial. The UK is unable to compete directly with Russia and China in vaccine production; however, by cooperating with India, the UK has been able to increase its production capacity to the point where the UK’s vaccine will now become the most widespread vaccine administered across the globe. To conclude his presentation, Dr. Wright stated that while it is unclear what biotech engineers would create, the vast amount of genetic data stored on applications such as Ancestry.com and hospital computers does present an active security threat.
Dr. Giordano began his remarks by emphatically stating that COVID-19 is not a man-made biological weapon. However, it is realistic to assume that countries have paid attention to each other’s capabilities to defend against this biological agent. He asserted that the US did not appear to be well-prepared to deal with the initial outbreak of COVID-19, despite having participated in modeling and simulation exercises to prepare for the outbreak of a contagion. He then reiterated Dr. Wright’s statement that China has used its ability to supply countries with medical supplies to create medical dependencies. China’s autocratic political system has aided it in the creation of these medical supplies, in addition to biomechanical instruments and technology, because it can fuse actions from its private and government sectors together with ease. Dr. Giordano concluded by agreeing with Dr. Wright’s assessment that the best way to counter China’s ability to coordinate its efforts across its military, civilian, and economic sectors is for the US to cooperate with its allies.
Next, Dr. DiEuliis argued that the US’s ability to innovate and create its own supplies has decreased since WWII. Part of the reason behind the US’s weakened ability to innovate is many of the US companies responsible for innovation do not know how to work with the USG. However, Dr. DiEuliis believes that the US demonstrated that it could still significantly increase its ability to innovate and manufacture through its quick development and production of its multiple COVID-19 vaccines. She concluded by explaining that the USG will be more prepared to deal with biotechnical issues in the future if it finds a way to increase cooperation between the USG and the US private sector.
Note: We are aware that many government IT providers have blocked access to YouTube from government machines during the pandemic in response to bandwidth limitations. We recommend viewing the recording on YouTube from a non-government computer or listening to the audio file (below), if you are in this position.
Dr. Nicholas Wright (Georgetown University, University College London, New America)
Dr. Nicholas D. Wright is a medical doctor, works on technology and global politics, and is affiliated with Georgetown University Medical Center, University College London and New America. He works closely with the Pentagon Joint Staff and collaborates with Peking University. He has many academic publications, more generally in the Atlantic, Foreign Affairs, Foreign Policy, National Interest etc. and has appeared on BBC and CNN. See www.intelligentbiology.co.uk.
Dr. James Giordano (Georgetown University, US Naval War College)
Dr. James Giordano is Professor of Neurology; Chief of Neuroethics Studies; and Co-Director of the Program in Brain Science and Global Law and Policy at Georgetown University. Author of over 300 publications, he is also Senior Fellow in Biosecurity, Technology and Ethics of the US Naval War College, and has served as senior advisor to the OECD on trans-Pacific biotechnology issues.
Dr. Diane DiEuliis (National Defense University)
Dr. Diane DiEuliis is a Senior Research Fellow at National Defense University, focusing on biothreats and emerging biotechnologies. Previously, she coordinated policy in support of domestic and international health emergency preparedness and response at Health and Human Services, and from 2007 to 2011 was the Assistant Director for Life Sciences in the Office of Science and Technology Policy at the White House.
Our speakers’ recent National Interest piece can be found at https://nationalinterest.org/feature/3-tricks-strategically-competing-global-innovation-smackdown-178456
The SMA NDU Innovation Speaker Series description and list of the other sessions in this series can be downloaded here.
Comments